Home / VCNX : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does VCNX make money? Does VCNX have pricing power? What's the Earnings Whisper? Will VCNX profit more as the business scales? What is VCNX's management track record? Is VCNX's current price justified?

Vaccinex, Inc.

$1.06 -$0.07 (-6.19%)

OTC · 14 Sep 2026 20:00 UTC

Previous Close

$1.05

Day Range

$1.05$1.06

Year Range

$0.31$1.5

Market Cap

2.84M

AVG Volume

1.75K

Trailing/Forward PE

-0.54/-

PEG ratio

-0

Dividend Yield

Next Earnings Date

2026-11-16

Primary Exchange

Other OTC

Revenue (USD) · TTM

VCNX Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
24 Q4	601K
24 Q3	2K
24 Q2	-30K
24 Q1	-262K
23 Q4	184K
23 Q3	620K
23 Q2	650K
23 Q1	650K
22 Q4	100K
22 Q3	900K

Net Income (USD) · TTM

VCNX Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
24 Q4	-18.63M
24 Q3	-18.58M
24 Q2	-17.76M
24 Q1	-19.19M
23 Q4	-20.23M
23 Q3	-21.99M
23 Q2	-21.84M
23 Q1	-20.14M
22 Q4	-19.8M
22 Q3	-19.35M

Operating Income (USD) · TTM

VCNX Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
24 Q4	-18.73M
24 Q3	-20.34M
24 Q2	-21.62M
24 Q1	-22.97M
23 Q4	-22.89M
23 Q3	-23.02M
23 Q2	-21.97M
23 Q1	-20.3M
22 Q4	-19.91M
22 Q3	-20.3M

EBITDA (USD) · TTM

VCNX EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
24 Q4	-18.51M
24 Q3	-18.06M
24 Q2	-17.23M
24 Q1	-18.66M
23 Q4	-19.75M
23 Q3	-21.88M
23 Q2	-21.68M
23 Q1	-19.98M
22 Q4	-19.61M
22 Q3	-19.16M

Cash Flows (USD) · TTM

VCNX Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
24 Q4	-16.21M
24 Q3	-15.87M
24 Q2	-15.77M
24 Q1	-16.84M
23 Q4	-17.3M
23 Q3	-18.31M
23 Q2	-19.39M
23 Q1	-19.27M
22 Q4	-19.17M
22 Q3	-19.74M

EPS (USD) · TTM

VCNX EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
24 Q4	-10.48
24 Q3	-17.31
24 Q2	-29.74
24 Q1	-51.18
23 Q4	-69.03
23 Q3	-85.65
23 Q2	-93.81
23 Q1	-95.68
22 Q4	-99.79
22 Q3	-106.3

Expenses (USD) · TTM

VCNX Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
24 Q4	19.36M
24 Q3	20.72M
24 Q2	21.98M
24 Q1	23.09M
23 Q4	23.5M
23 Q3	23.88M
23 Q2	22.89M
23 Q1	21.27M
22 Q4	20.28M
22 Q3	20.48M

Shares Outstanding (USD) · TTM

VCNX Shares Outstanding (USD) · TTM by quarter
Period	Shares Outstanding (USD) · TTM
24 Q4	-341K
24 Q3	-388K
24 Q2	-427K
24 Q1	-441K
23 Q4	-474K
23 Q3	-502K
23 Q2	-521K
23 Q1	-533K
22 Q4	-545K
22 Q3	-566K

Employee Count

VCNX Employee Count by quarter
Period	Employee Count
2024	23
2023	37
2022	38
2021	39
2020	39
2019	45
2018	44

Free Cash Flow Yield

VCNX Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-728.49%
Sep 26	-735.43%
Sep 26	-1029.6%
Aug 26	-772.2%
Aug 26	-702%
Aug 26	-930.36%
Aug 26	-780%
Jul 26	-908.47%
Jul 26	-654.4%
Jul 26	-671.48%
Jul 26	-598.6%
Jul 26	-757.06%
Jun 26	-1002.85%
Jun 26	-695.67%
Jun 26	-764.55%
Jun 26	-772.2%
May 26	-772.2%
May 26	-772.2%
May 26	-702%
May 26	-764.55%
May 26	-772.2%
Apr 26	-735.43%
Apr 26	-772.2%
Apr 26	-772.2%
Apr 26	-772.2%
Mar 26	-648.9%
Mar 26	-869.59%
Mar 26	-1103.14%
Mar 26	-968.27%
Feb 26	-749.71%
Feb 26	-749.71%
Feb 26	-617.76%
Feb 26	-643.5%
Jan 26	-563.65%
Jan 26	-580.6%
Jan 26	-572%
Jan 26	-772.2%
Jan 26	-683.36%
Dec 25	-708.44%
Dec 25	-977.46%
Dec 25	-1544.08%
Dec 25	-1103.14%
Nov 25	-1103.3%
Nov 25	-1103.14%
Nov 25	-1105.51%
Nov 25	-1104.72%
Oct 25	-1223.57%
Oct 25	-878.79%
Oct 25	-1608.74%
Oct 25	-1514.11%
Oct 25	-1206.56%
Sep 25	-1043.51%
Sep 25	-1103.14%
Sep 25	-1218.94%
Sep 25	-1456.97%
Aug 25	-1544.39%
Aug 25	-772.2%
Aug 25	-986.08%
Aug 25	-1103.14%
Aug 25	-977.55%
Jul 25	-1087.6%
Jul 25	-848.57%
Jul 25	-821.49%
Jul 25	-1103.93%
Jun 25	-1057.8%
Jun 25	-1087.6%
Jun 25	-941.7%
Jun 25	-897.9%
May 25	-839.34%
May 25	-1135.58%
May 25	-742.5%
May 25	-1135.58%
May 25	-1152.53%
Apr 25	-858%
Apr 25	-1043.51%
Apr 25	-1118.38%
Apr 25	-1304.77%
Mar 25	-1043.82%
Mar 25	-1373.44%
Mar 25	-1057.92%
Mar 25	-841.79%
Feb 25	-711.69%
Feb 25	-760.06%
Feb 25	-899.84%
Feb 25	-767.51%
Jan 25	-652.39%
Jan 25	-669.11%
Jan 25	-724.87%
Jan 25	-680.75%
Jan 25	-652.39%
Dec 24	-718.22%
Dec 24	-646.99%
Dec 24	-212.16%
Dec 24	-200.22%
Nov 24	-207.11%
Nov 24	-216.26%
Nov 24	-247.74%
Nov 24	-279.82%
Nov 24	-294.05%
Oct 24	-256.64%

Price to Sales

VCNX Price to Sales by quarter
Period	Price to Sales
Sep 26	3.7
Sep 26	3.67
Sep 26	2.62
Aug 26	3.49
Aug 26	3.84
Aug 26	2.9
Aug 26	3.46
Jul 26	2.97
Jul 26	4.12
Jul 26	4.02
Jul 26	4.51
Jul 26	3.56
Jun 26	2.69
Jun 26	3.88
Jun 26	3.53
Jun 26	3.49
May 26	3.49
May 26	3.49
May 26	3.84
May 26	3.53
May 26	3.49
Apr 26	3.67
Apr 26	3.49
Apr 26	3.49
Apr 26	3.49
Mar 26	4.16
Mar 26	3.1
Mar 26	2.44
Mar 26	2.79
Feb 26	3.6
Feb 26	3.6
Feb 26	4.37
Feb 26	4.19
Jan 26	4.78
Jan 26	4.64
Jan 26	4.71
Jan 26	3.49
Jan 26	3.95
Dec 25	3.81
Dec 25	2.76
Dec 25	1.75
Dec 25	2.44
Nov 25	2.44
Nov 25	2.44
Nov 25	2.44
Nov 25	2.44
Oct 25	2.2
Oct 25	3.07
Oct 25	1.68
Oct 25	1.78
Oct 25	2.24
Sep 25	2.58
Sep 25	2.44
Sep 25	2.21
Sep 25	1.85
Aug 25	1.75
Aug 25	3.49
Aug 25	2.73
Aug 25	2.44
Aug 25	2.76
Jul 25	2.48
Jul 25	3.18
Jul 25	3.28
Jul 25	2.44
Jun 25	2.55
Jun 25	2.48
Jun 25	2.86
Jun 25	3
May 25	3.21
May 25	2.37
May 25	3.63
May 25	2.37
May 25	2.34
Apr 25	3.14
Apr 25	2.58
Apr 25	709.42
Apr 25	608.08
Mar 25	760.1
Mar 25	577.67
Mar 25	749.96
Mar 25	942.52
Feb 25	1114.81
Feb 25	1043.86
Feb 25	881.71
Feb 25	1033.73
Jan 25	1216.15
Jan 25	1185.75
Jan 25	1094.54
Jan 25	1165.48
Jan 25	1216.15
Dec 24	1104.67
Dec 24	1226.29
Dec 24	3739.67
Dec 24	3962.63
Nov 24	3830.88
Nov 24	3668.73
Nov 24	3202.53
Nov 24	-187.81
Nov 24	-178.72
Oct 24	-204.77

Price to Book

VCNX Price to Book by quarter
Period	Price to Book
Aug 24	2.29
Aug 24	2.61
Jul 24	3.36
Jul 24	3.55
Jul 24	3.29
Jul 24	3.32
Jun 24	3.24
Jun 24	3.05
Jun 24	3.43
Jun 24	3.71
May 24	3.39
May 24	2.7
May 24	2.77
Aug 23	5.38
Aug 23	5.58
Jul 23	5.79
Jul 23	6.41
Jul 23	6.41
Jul 23	7.44
Jun 23	7.44
Jun 23	7.24
Jun 23	7.86
Jun 23	9.51
Jun 23	8.68
May 23	8.48
May 23	8.27
May 23	3.28
May 23	2.87
Apr 23	2.95
Apr 23	3.28
Apr 23	3.52
Apr 23	3.28
Mar 23	3.28
Mar 23	2.77
Mar 23	2.77
Mar 23	2.9
Mar 23	3.44
Feb 23	3.11
Feb 23	3.44
Feb 23	3.85
Feb 23	3.98
Jan 23	4.05
Jan 23	3.98
Jan 23	4.32
Jan 23	4.32
Dec 22	4.32
Dec 22	4.59
Dec 22	4.73
Dec 22	4.39
Dec 22	4.39
Nov 22	2.97
Nov 22	3.51
Nov 22	2.27
Nov 22	2.16
Oct 22	2.19
Oct 22	1.85
Oct 22	2.04
Oct 22	2.23
Sep 22	1.89
Sep 22	1.82
Sep 22	3.03
Sep 22	2.76
Sep 22	3.03
Aug 22	3.75
Aug 22	3.78
Aug 22	2.6
Aug 22	2.44
Jul 22	2.48
Jul 22	2.65
Jul 22	2.79
Jul 22	2.79
Jul 22	2.46
Jun 22	2.7
Jun 22	2.53
Jun 22	3
Jun 22	3.19
May 22	3
May 22	2.84
May 22	4.82
May 22	5.1
Apr 22	5.34
Apr 22	5.06
Apr 22	4.98
Apr 22	5.26
Apr 22	5.22
Mar 22	3.6
Mar 22	3.78
Mar 22	3.11
Mar 22	2.82
Feb 22	3.76
Feb 22	3.26
Feb 22	4.59
Feb 22	4.27
Jan 22	2.93
Jan 22	2.69
Jan 22	2.9
Jan 22	2.9
Dec 21	2.69
Dec 21	3.37
Dec 21	3.42

No video analysis for this stock yet. Request one from our team.

News: VCNX

globenewswire.com · 8 Jul 2026

Vaccinex to Report New Biomarker Data and Plans for Phase 2B Clinical Trial of Pepinemab in AD at the Alzheimer's Association International Conference in London on July 13, 2026

ROCHESTER, N.Y., July 08, 2026 (GLOBE NEWSWIRE) -- Vaccinex, Inc., a clinical-stage biotechnology company pioneering a differentiated approach to treating Alzheimer's disease (AD) through the inhibition of Semaphorin 4D (SEMA4D), today announced that it will present promising new biomarker data from its Phase 1b/2 trial to support plans for an enlarged randomized phase 2B SIGNAL-AD study of pepinemab for treatment for early Alzheimer's disease at the Alzheimer's Association International Conference in London, United Kingdom, on July 13, 2026.

AI Analysis

Vaccinex, Inc.

Video analysis: VCNX

News: VCNX

Vaccinex to Report New Biomarker Data and Plans for Phase 2B Clinical Trial of Pepinemab in AD at the Alzheimer's Association International Conference in London on July 13, 2026

Similar companies